First Time Loading...

ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.39 USD -6.08% Market Closed
Updated: Jun 9, 2024

ATAI Life Sciences NV
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ATAI Life Sciences NV
Operating Expenses Peer Comparison

Comparables:
BAYN
MRK
93M1
DMP
PSG

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
ATAI Life Sciences NV
NASDAQ:ATAI
Operating Expenses
-$125.8m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Operating Expenses
-€26.8B
CAGR 3-Years
10%
CAGR 5-Years
-6%
CAGR 10-Years
-6%
Merck KGaA
XETRA:MRK
Operating Expenses
-€8.5B
CAGR 3-Years
-4%
CAGR 5-Years
-2%
CAGR 10-Years
-3%
MPH Health Care AG
XETRA:93M1
Operating Expenses
-€1m
CAGR 3-Years
-2%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Operating Expenses
-€541.7m
CAGR 3-Years
-17%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Operating Expenses
-€67m
CAGR 3-Years
-16%
CAGR 5-Years
-14%
CAGR 10-Years
N/A

See Also

What is ATAI Life Sciences NV's Operating Expenses?
Operating Expenses
-125.8m USD

Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Operating Expenses amounts to -125.8m USD.

What is ATAI Life Sciences NV's Operating Expenses growth rate?
Operating Expenses CAGR 3Y
-11%

Over the last year, the Operating Expenses growth was 13%. The average annual Operating Expenses growth rates for ATAI Life Sciences NV have been -11% over the past three years .